How did AZN's Q4 2024 earnings surprise investors?
3/29/2025 04:10pm
Astrazeneca's (AZN) Q4 2024 earnings exceeded investor expectations, with the EPS surprise standing at $1.03. This positive outcome reflects the company's strong financial performance during the period, likely attributed to factors such as effective cost management, robust revenue growth, or strategic business initiatives. Investors generally respond favorably to earnings surprises, as they indicate better-than-expected profitability, which can lead to increased investor confidence and potential stock price appreciation.